R&D Systems™ Recombinant Human CLEC14A Fc Chimera Protein

Catalog No.	Quantity
96-64C-L050	50 μg

Catalog No. 96-64C-L050 Supplier R&D Systems™ Supplier No. 9664CL050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human CLEC14A Fc Chimera Protein is derived from HEK293. The Recombinant Human CLEC14A Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q86T13
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 161198
• Molecular Weight (g/mol): 66 kDa
• Name: C14orf27, CEG1, chromosome 14 open reading frame 27, ClECT and EGF-like domain containing protein, C-type lectin domain family 14 member A, C-type lectin domain family 14, member A, EGF R5, EGFR5, EGFR-5, Epidermal growth factor receptor 5
• Quantity: 50 μg
• Source: Human embryonic kidney cell,HEK293-derived human CLEC14A protein, (N-terminus) Human CLEC14A (Glu22-Ala397) Accession &Num; Q86T13 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.